CG Oncology, Inc. Common stockCGONNASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+75.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
5.4x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $190.17M | +64.2% |
| 2024 | $115.81M | +108.1% |
| 2023 | $55.65M | +57.1% |
| 2022 | $35.42M | +54.3% |
| 2021 | $22.95M | - |